Naltrexone, Naloxone, Morphine, and Fentanyl Pharmacologically Chaperone a Mutant μ‐Opioid Receptor via an Endoplasmic Reticulum Exit Site‐Dependent Pathway

{"Opioid":[0],"receptor":[1,89,103],"antagonists":[2],"increase":[3,128],"the":[4,23,46,51,63,129,132,205,228,236],"plasma":[5,52],"membrane":[6,53],"density":[7,54],"of":[8,25,48,55,131,220,238],"μ-opioid":[9,88],"receptors":[10],"(MOR)":[11,90],"in":[12,27,100],"vivo,":[13],"thereby":[14],"inducing":[15],"\\"supersensitivity\\"":[16],"to":[17,81,192],"opioid":[18,102,222,239],"agonists.":[19],"This":[20],"phenomenon":[21],"increases":[22],"risk":[24],"overdose":[26],"patients":[28],"that":[29,115,122,197],"were":[30],"being":[31],"treated":[32],"with":[33,118],"naltrexone":[34],"(Ntx),":[35],"a":[36,85],"popular":[37],"MOR":[38,60,159,225],"antagonist.":[39],"Although":[40],"there":[41],"are":[42],"many":[43],"studies":[44],"on":[45,50,59,149,202],"effects":[47,58],"ligands":[49,223],"MORs,":[56],"their":[57],"trafficking":[61,188,226],"from":[62,106,204,227],"endoplasmic":[64,68],"reticulum":[65,69],"(ER)":[66],"via":[67],"exit":[70],"sites":[71],"(ERES)":[72],"have":[73,145],"not":[74,170,178,190],"been":[75],"investigated.":[76],"Using":[77],"fluorescently":[78],"tagged":[79],"Sec24":[80],"visualize":[82],"ERES":[83,96,150],"and":[84,126,141,163,230],"highly":[86],"ER-retained":[87],"point":[91],"mutant,":[92],"MOR[N190K],":[93],"we":[94],"measured":[95],"levels":[97],"after":[98],"incubation":[99],"various":[101],"ligands.":[104],"Data":[105],"sensitized":[107],"emission":[108],"Förster":[109],"resonance":[110],"energy":[111],"transfer":[112],"(FRET)":[113],"show":[114],"MOR[N190K]":[116],"interacts":[117],"Sec24D.":[119],"We":[120,194],"observe":[121],"Ntx,":[123],"naloxone,":[124],"morphine,":[125],"fentanyl":[127],"fraction":[130],"cytoplasm":[133],"occupied":[134],"by":[135],"ERES.":[136],"In":[137],"contrast,":[138],"buprenorphine,":[139],"methadone,":[140],"two":[142],"allosteric":[143],"modulators":[144],"no":[146],"substantial":[147],"effect":[148],"levels.":[151],"Mutating":[152],"S375,":[153],"an":[154],"important":[155],"phosphorylation":[156],"site":[157],"for":[158],"internalization,":[160],"decreased":[161],"morphine":[162],"fentanyl's":[164],"pharmacological":[165,173,199,213],"chaperoning":[166,174,200],"abilities":[167],"but":[168],"did":[169,177],"affect":[171],"Ntx's":[172],"abilities.":[175],"Ntx":[176],"change":[179,224],"intracellular":[180],"cyclic":[181],"adenosine":[182],"monophosphate":[183],"(cAMP)":[184],"concentrations,":[185],"so":[186],"global":[187],"is":[189],"expected":[191],"change.":[193],"also":[195],"find":[196],"antagonist-induced":[198],"depends":[201],"retrotransport":[203],"Golgi":[206],"as":[207],"brefeldin":[208],"A":[209],"(BFA)":[210],"treatment":[211],"prevented":[212],"chaperoning.":[214],"These":[215],"data":[216],"reveal":[217],"new":[218],"understandings":[219],"how":[221],"ER":[229],"can":[231],"help":[232],"us":[233],"better":[234],"understand":[235],"pathophysiology":[237],"use":[240],"disorder.":[241]}